Emyria Limited Price Chart
Emyria Limited EMD.XA Financial and Trading Overview
| Emyria Limited stock price | 0.06 AUD |
| Previous Close | 0.13 AUD |
| Open | 0.13 AUD |
| Bid | 0.12 AUD x N/A |
| Ask | 0.13 AUD x N/A |
| Day's Range | 0.12 - 0.13 AUD |
| 52 Week Range | 0.12 - 0.33 AUD |
| Volume | 113.41K AUD |
| Avg. Volume | 132.64K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.84942 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.027 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EMD.XA Valuation Measures
| Enterprise Value | 34.94M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.9444447 |
| Enterprise Value/Revenue | 19.718 |
| Enterprise Value/EBITDA | -5.068 |
Trading Information
Emyria Limited Stock Price History
| Beta (5Y Monthly) | 0.84942 |
| 52-Week Change | -37.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.33 AUD |
| 52 Week Low | 0.12 AUD |
| 50-Day Moving Average | 0.15 AUD |
| 200-Day Moving Average | 0.19 AUD |
EMD.XA Share Statistics
| Avg. Volume (3 month) | 132.64K AUD |
| Avg. Daily Volume (10-Days) | 81.02K AUD |
| Shares Outstanding | N/A |
| Float | 130.3M |
| Short Ratio | N/A |
| % Held by Insiders | 50.91% |
| % Held by Institutions | 6.90% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -395.94% |
| Gross Margin | -32.51% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -44.93% |
| Return on Equity (ttm) | -100.27% |
Income Statement
| Revenue (ttm) | 1.77M AUD |
| Revenue Per Share (ttm) | 0.006 AUD |
| Quarterly Revenue Growth (yoy) | -6.40% |
| Gross Profit (ttm) | -525254 AUD |
| EBITDA | -6894726 AUD |
| Net Income Avi to Common (ttm) | -7635326 AUD |
| Diluted EPS (ttm) | -0.027 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.72M AUD |
| Total Cash Per Share (mrq) | 0.009 AUD |
| Total Debt (mrq) | 1.31M AUD |
| Total Debt/Equity (mrq) | 24.55 AUD |
| Current Ratio (mrq) | 1.213 |
| Book Value Per Share (mrq) | 0.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6445444 AUD |
| Levered Free Cash Flow (ttm) | -5756356 AUD |
Profile of Emyria Limited
| Country | Australia |
| State | WA |
| City | Leederville |
| Address | D2, 661 Newcastle Street |
| ZIP | 6007 |
| Phone | 61 8 6559 2800 |
| Website | https://emyria.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
Q&A For Emyria Limited Stock
What is a current EMD.XA stock price?
Emyria Limited EMD.XA stock price today per share is 0.06 AUD.
How to purchase Emyria Limited stock?
You can buy EMD.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Emyria Limited?
The stock symbol or ticker of Emyria Limited is EMD.XA.
How many shares does Emyria Limited have in circulation?
The max supply of Emyria Limited shares is 0.
What is Emyria Limited Price to Earnings Ratio (PE Ratio)?
Emyria Limited PE Ratio is now.
What was Emyria Limited earnings per share over the trailing 12 months (TTM)?
Emyria Limited EPS is -0.027 AUD over the trailing 12 months.